Viewing Study NCT01025505


Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-04-10 @ 7:03 PM
Study NCT ID: NCT01025505
Status: COMPLETED
Last Update Posted: 2022-10-12
First Post: 2009-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module